{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T01:14:53Z","timestamp":1774142093835,"version":"3.50.1"},"reference-count":7,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["215633"],"award-info":[{"award-number":["215633"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["wellcomeopenresearch.org"],"crossmark-restriction":false},"short-container-title":["Wellcome Open Res"],"abstract":"<ns3:p>\n                    Background Health service programmes frequently encounter challenges with patient adherence to care. A promising, low-risk approach to address this issue is providing patients with targeted information about the importance of adherence. In the Vision Impact Project (VIP), an eye health screening programme in Kenya, the adherence rate to attending triage clinics after referral is around 50%. To improve this rate, this trial will test the effectiveness of delivering relevant information to patients at the point of referral along with reminder messages. Methods A pragmatic, Bayesian adaptive trial will be conducted within the VIP programme to assess the effectiveness of providing enhanced information compared to standard care. Weekly interim analyses will monitor adherence rates to referral appointments following positive vision impairment screenings. Participants will be randomized equally into intervention and control groups. The trial will stop if interim findings indicate either efficacy of one arm over the other, or futility that the two arms are performing equally. Discussion This paper presents the statistical analysis plan for a pragmatic adaptive trial aimed at improving adherence in an eye screening programme in Kenya. This statistical analysis plan expands on the design and analysis plan detailed in the study protocol and documents decision rules to avoid post hoc decision-making. Trial registration ISRCTN 11329596, Registered on 02 February 2024,\n                    <ns3:ext-link xmlns:ns4=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" ns4:href=\"https:\/\/doi.org\/10.1186\/ISRCTN11329596\">https:\/\/doi.org\/10.1186\/ISRCTN11329596<\/ns3:ext-link>\n                  <\/ns3:p>","DOI":"10.12688\/wellcomeopenres.23495.1","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T11:10:07Z","timestamp":1739445007000},"page":"69","update-policy":"https:\/\/doi.org\/10.12688\/wellcomeopenres.crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Enhanced patient counselling and SMS reminder messages to improve access to community-based eye care services in Meru, Kenya: statistical analysis plan for a Bayesian adaptive trial"],"prefix":"10.12688","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3561-9308","authenticated-orcid":false,"given":"Min Jung","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2750-3575","authenticated-orcid":false,"given":"Luke","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malebogo","family":"Tlhajoane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5001-0061","authenticated-orcid":false,"given":"David","family":"Prieto-Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Bolster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bastawrous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2371-5709","authenticated-orcid":false,"given":"David","family":"Macleod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"ref-1","article-title":"Identifying barriers and potential solutions to improve equitable access to community eye services in central Kenya: a rapid exploratory sequential mixed methods study.","author":"L Allen","journal-title":"BMJ Open."},{"key":"ref-2","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.28.24303254","article-title":"Protocol for an individual-level, two arm, superiority RCT within an adaptive platform trial: enhanced patient counselling and SMS reminder messages to improve access to community-based eye care services in Meru, Kenya.","author":"L Allen","year":"2024","journal-title":"medRxiv."},{"key":"ref-3","article-title":"Lecture 4. Study designs in a Bayesian framework, in survival analysis and Bayesian statistics (2463).","year":"2023"},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"90-100","DOI":"10.1016\/j.jtbi.2006.02.002","article-title":"Prior specification in Bayesian statistics: three cautionary tales.","volume":"242","author":"S Van Dongen","year":"2006","journal-title":"J Theor Biol."},{"key":"ref-5","article-title":"Bayesian adaptive methods for clinical trials.","author":"S Berry","year":"2011"},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"523-9","DOI":"10.1046\/j.0306-5251.2001.01381.x","article-title":"Stopping rules for phase II studies.","volume":"51","author":"N Stallard","year":"2001","journal-title":"Br J Clin Pharmacol."},{"key":"ref-7","doi-asserted-by":"crossref","DOI":"10.12688\/wellcomeopenres.23495.1","article-title":"Enhanced patient counselling and SMS reminder messages to improve access to community-based eye care services in Meru, Kenya: statistical analysis plan for a Bayesian adaptive trial","author":"M Kim","year":"2025"}],"container-title":["Wellcome Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/10-69\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/10-69\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/10-69\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T12:20:27Z","timestamp":1743250827000},"score":1,"resource":{"primary":{"URL":"https:\/\/wellcomeopenresearch.org\/articles\/10-69\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,13]]},"references-count":7,"URL":"https:\/\/doi.org\/10.12688\/wellcomeopenres.23495.1","relation":{"has-review":[{"id-type":"doi","id":"10.21956\/wellcomeopenres.25915.r118773","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.25915.r119238","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.25915.r119238","asserted-by":"object"},{"id-type":"doi","id":"10.21956\/wellcomeopenres.25915.r118773","asserted-by":"object"}]},"ISSN":["2398-502X"],"issn-type":[{"value":"2398-502X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,13]]},"assertion":[{"value":"Indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/10-69\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.21956\/wellcomeopenres.25915.r119238, Cathy Egan, Abraham Olvera-Barrios, Moorfields Eye Hospital, London, 25 Mar 2025, version 1, indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/10-69\/v1#referee-response-119238","order":0,"name":"referee-response-119238","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.21956\/wellcomeopenres.25915.r118773, Khin Than Win, University of Wollongong, Wollongong, 29 Mar 2025, version 1, indexed","URL":"https:\/\/wellcomeopenresearch.org\/articles\/10-69\/v1#referee-response-118773","order":1,"name":"referee-response-118773","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work was supported by Wellcome [215633] and the National Institute for Health Research (NIHR) (using the UK\u2019s Official Development Assistance (ODA) Funding). The views expressed are those of the authors and not necessarily those of Wellcome, the NIHR or the Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}